By Bruce Chabner, Jr., Thomas Lynch, Dan Longo
A CONCISE but THOROUGH review OF THE medicines AND ways utilized in melanoma CARE--BACKED by way of THE AUTHORITY OF HARRISON'S
Harrison's guide of Oncology is a carry-anywhere advisor to the care of sufferers with melanoma. more suitable by way of the newest released effects, this useful medical significant other beneficial properties various tables and succinct, outline-style textual content that places vital info at your fingertips. you can find content material that is going past the remedy of fundamental or metastatic affliction to surround the therapy of all healing complications.
The commencing sections of Harrison's handbook of Oncology are dedicated to the periods of brokers used to regard melanoma and experiences their pharmacology and mechanisms of motion. This part is via an in depth dialogue of the prognosis, staging, and therapy of all significant kinds of melanoma. there's a powerful concentrate on symptom administration and problems of remedy, together with soreness, nausea and vomiting, anemia, febrile neutropenia, metabolic emergencies, thrombosis, mental matters, and end-of-life care.
Read or Download Harrisons Manual of Oncology 2/E PDF
Best oncology books
Energy Balance and Gastrointestinal Cancer
The gastrointestinal song presents one of many detailed structures the place a number of malignancies, together with adenocarcinoma of the pancreas, esophagus and colon are each one linked to weight problems. This specified organization is roofed during this quantity of power stability and melanoma from the epidemiologic, biologic and capability etiologic standpoint.
Brain Metastases from Primary Tumors. Epidemiology, Biology, and Therapy
With an annual fee of greater than 12 million worldwide diagnoses and seven. 6 million deaths, the societal and financial burden of melanoma can't be overstated. mind metastases are the commonest malignant tumors of the critical worried process, but their occurrence seems to be expanding even with the development of melanoma treatments.
Branching Process Models of Cancer
This quantity develops effects on non-stop time branching tactics and applies them to review fee of tumor development, extending vintage paintings at the Luria-Delbruck distribution. as a result, the writer calculate the chance that mutations that confer resistance to therapy are current at detection and quantify the level of tumor heterogeneity.
- Textbook of Medical Oncology (Fourth Edition) (Cavalli Textbook of Medical Oncology)
- Drug Discovery Strategies and Methods
- Peptide-Based Cancer Vaccines (Medical Intelligence Unit)
- Management of Soft Tissue Sarcoma
- Early Diagnosis and Treatment of Cancer Series: Head and Neck Cancers: Expert Consult - Online and Print, 1e
- Targeting the Wnt Pathway in Cancer
Additional resources for Harrisons Manual of Oncology 2/E
Example text
Doses should be modified in proportion to the reduction in renal function for patients with a creatinine clearance of less than 60 ml/ min. Nonsteroidal anti-inflammatory drugs reduce renal blood flow and displace methotrexate from plasma protein binding, thereby slowing clearance and increasing unbound drug concentrations in plasma, and should not be used in conjunction with methotrexate. Proton pump inhibitors may displace the drug from albumin binding and increase its toxicity. Penicillins reduce methotrexate secretion by renal tubules and may also increase the risk of toxicity.
Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474: 609–615. Sequist LV, Heist RS, Shaw AT, et al. Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice. Ann Oncol. 2011; 22: 2616–2624. Von Hoff DD, Stephenson JJ Jr, Rosen P, et al. Pilot study using molecular profiling of patients’ tumors to find potential targets and select treatments for their refractory cancers. J Clin Oncol. 2010; 28: 4877–4883. Chapman PB, Hauschild A, Robert C, et al.
Cytidine deaminase (CDA) is found in most human tissues, including epithelial cells of the intestine, the liver, and even in plasma. Elevated concentrations of CDA have been implicated as the cause of ara-C resistance in AML, but the evidence is as yet not convincing. Polymorphic variants of CDA (C-451T) decrease enzyme levels and are associated with greater toxicity and poorer survival (13). The most important cause of resistance appears to be a deletion of deoxycytidine kinase activity. Other evidence suggests that the pharmacokinetics (degree of formation and the duration of persistence) of ara-CTP in leukemic cells determine the therapeutic outcome.